Talis Biomedical

TLIS · OTC

Price unavailable right now.

No price history for this range.

About TLIS

The company is headquartered in Chicago, Illinois and currently employs 99 full-time employees. The company went IPO on 2021-02-12.

Employees
99
Headquarters
Chicago, Illinois
Listed
Feb 12, 2021
Sector
Health Care
Industry
Health Care Equipment & Supplies

TLIS key statistics

This section is temporarily unavailable. Refresh to try again.

TLIS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 7.6% on average.

  1. Q3 FY21: reported -$22.35 per share against an estimate of -$21.42
  2. Q4 FY21: reported -$18.90 per share against an estimate of -$19.63
  3. Q1 FY22: reported -$18.75 per share against an estimate of -$18.05
  4. Q2 FY22: reported -$15.15 per share against an estimate of -$12.32
  5. Q3 FY22: reported -$14.70 per share against an estimate of -$11.93
  6. Q4 FY22: reported -$15.00 per share against an estimate of -$10.48
  7. Q1 FY23: reported -$9.90 per share against an estimate of -$11.17
  8. Q3 FY23: reported -$8.62 per share against an estimate of -$7.52

TLIS news

  • Avi Kapoor

    Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

  • Avi Kapoor

    Dow Tumbles Over 200 Points; CVS Health Cuts Profit Forecast

  • Avi Kapoor

    Crude Oil Jumps Over 3%; Upstart Shares Spike Higher

  • Avi Kapoor

    Nasdaq Jumps 250 Points; Disney Earnings Beat Estimates

  • Henry Khederian

    Why Talis Biomedical (TLIS) Stock Is Getting Obliterated Today

  • Avi Kapoor

    Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Similar companies

Companies in the same industry as Talis Biomedical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.